insulin human - search results

বসনিয়া ও হার্জেগোভিনা - ক্রোয়েশীয় - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

semglee (▼) 100 jedinica/1 ml rastvor za injekciju u napunjenom penu

viatris bh d.o.o. - гларгин inzulin - rastvor za injekciju u napunjenom penu - 100 jedinica/1 ml - jedan ml rastvora za injekciju u napunjenom penu sadrži: 100 jedinica insulina glargina (što odgovara 3,64 mg)

fiasp flextouch (▼) 100 jedinica/1 ml rastvor za injekciju u napunjenom penu

novo nordisk pharma d.o.o. - inzulin aspart - rastvor za injekciju u napunjenom penu - 100 jedinica/1 ml - 1 ml rastvora za injekciju u napunjenom penu sadrži : 100 jedinica insulina aspart (što odgovara 3,5 mg)

ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

lyumjev (previously liumjev)

eli lilly nederland b.v. - inzulin lispro - Šećerna bolest - lijekovi koji se koriste u dijabetesu - liječenje dijabetes melitusa kod odraslih, adolescenata i djece u dobi od 1 godine i više. liječenje dijabetes melitusa kod odraslih.

abasaglar 100 jedinica/1 ml otopina za injekciju u napunjenoj brizgalici

eli lilly bh d.o.o. - гларгин inzulin - otopina za injekciju u napunjenoj brizgalici - 100 jedinica/1 ml - jedan ml otopine za injekciju sadrži: 100 jedinica (3,64 mg) insulina glargina

ryzodeg 2.56 mg/1 ml+ 1.05 mg/1 ml rastvor za injekciju u ulošku

novo nordisk pharma d.o.o. - inzulin аспарт, inzulin degludek - rastvor za injekciju u ulošku - 2.56 mg/1 ml+ 1.05 mg/1 ml - 1 ml rastvora za injekciju sadrži: 100 jedinica inzulina degludek/inzulina aspart u omjeru 70/30 (što odgovara 2,56 mg degludek inzulina i 1,05 mg inzulina aspart)

toujeo 300 jedinica/1 ml rastvor za injekciju u napunjenom penu

amicus pharma d.o.o. - гларгин inzulin - rastvor za injekciju u napunjenom penu - 300 jedinica/1 ml - 1 ml rastvora za injekciju sadrži: 300 jedinica inzulina glargina ( što odgovara 10,91 mg)

xultophy 100 jedinica/1 ml+ 3,6 mg/1 ml otopina za injekciju

novo nordisk pharma d.o.o. - degludek inzulina, liraglutid - otopina za injekciju - 100 jedinica/1 ml+ 3,6 mg/1 ml - 1 ml otopine za injekciju sadrži: 100 jedinica degludek insulina 3,6 mg liraglutida

indivil 50 mg/1 tableta tableta

hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - vildagliptin - tableta - 50 mg/1 tableta - jedna tableta sadrži: 50 mg vildagliptina

indivil 50 mg/1 tableta tableta

hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - vildagliptin - tableta - 50 mg/1 tableta - jedna tableta sadrži: 50 mg vidagliptina

ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

onglyza

astrazeneca ab - Саксаглиптин - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - add-on combination therapyonglyza is indicated in adult patients aged 18 years and older with type-2 diabetes mellitus to improve glycaemic control:as monotherapy:in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance;as dual oral therapy:in combination with metformin, when metformin alone, with diet and exercise, does not provide adequate glycaemic control;in combination with a sulphonylurea, when the sulphonylurea alone, with diet and exercise, does not provide adequate glycaemic control in patients for whom use of metformin is considered inappropriate;in combination with a thiazolidinedione, when the thiazolidinedione alone with diet and exercise, does not provide adequate glycaemic control in patients for whom use of a thiazolidinedione is considered appropriate;as triple oral therapy:in combination with metformin plus a sulphonylurea when this regimen alone, with diet and exercise, does not provide adequate glycaemic control;as combination therapy with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.